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   The symptoms of benign prostatic hypertrophy consist of two major groups, ob-
structive symptoms and irritative symptoms. Uroflowmetry is a safe, easy and accurate me-
thod to assess the obstructive symptoms. Furthermore, electromyography of abdominal wall 
and the monitoring of rectal pressure is helpful to know involvement of abdominal straining. 
Cystometry provides us objective findings of bladder irritability in bladder outlet obstruction. 
Detrusor hyperreflexia was revealed in 55%, and uninhibited detrusor contraction was revea-
led in 22.5% of the patients with benign prostatic hypertrophy. The most sophisticated 
technique to estimate the volume of prostatic adenoma is transrectal ultrasonotomography. 
The value, cranio-caudal x left-right x antero-posterior axis length, has been proved to 
closey correlate to the resected volume of the prostatic adenoma. However there was no cor-
relation between the estimated prostatic volume and the severity of dysuria. The comparison 
of the uroflow rates before and after loading phentolamine is a helpful method to determine 
the sympathetic influence to lower urinary tract obstructions. This test differentiates functi-
onal obstruction from organic obstruction. Conservative pharmacological therapy on the pa-
tients with benign prostatic hypertrophy were also studied. The value of efficacy of prazocine 
hydrochloride (0.5-6.0 mg/day), Eviprostat® (6Tab/day), Prostetin® (200-400 mg/day), Ha-
chimi-Jiogan® (5 g and 7.5 g/day) on subjective symptoms were 47.8. 86.2, 58.5, 52.9 and 66.7 
  respectively. Ninety-one of the 141 patients with benign prostatic hypertrophy who visited 
the out-patient clinic in 1983 were given pharmacological treatment initially. Of those 91
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patients, 19 improved satisfactorily and 38 received prostatectomy during the follow up pe-
riod of 2 years and 6 months. There were only 9 patients who needed to continue the phar-
macological treatment without surgical treatment. Twenty-five patients were lost to followup.
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を有する患者では全尿道 抵抗 の軽 減 と して働 き,
UFM各パラメーターの 改善がみられる(Table2).
ただ し,器 質的閉塞が高度な症例では α遮断薬の投
与によってもUFMに 変化はみられず,逆 に交感神
経系 による機能的閉塞が高度な症例にお いては著明
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1B2回 の服 用 で す 。
種 々 の 放 出時 間 を 持 つ よう 製 剤 化 され た 、徐
放 性顯 粒(TimedpilDをカ プ セ ル に充 填 し ま
した の で 、急激 な 血 中濃 度 の 上昇 をお さ え 、
血 中 濃 度 の 持続 が 観察 され て い ま す。
従 って 、従来 の イ ン ドメタ シ ン に み られ た 消
化 器 障 害 、中枢 系 の 副作 用(頭 痛 、頭 重)の 発
現頻 度 を 低 下 させ る こ とが 二 重 盲検 試 験 で 確
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